XML 19 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (8,681,915) $ (8,173,389)
Adjustments to reconcile net loss to net cash used in operating activities:    
Provision for doubtful accounts 385,597 435,838
Depreciation and amortization 645,742 351,396
Loss on disposal of assets 6,938 476,745
Deferred income taxes 40,188 (127,736)
Stock-based compensation expense 1,106,454 1,103,976
Gain on deconsolidation of variable interest entity (242,411) 0
Loss on debt extinguishment 0 266,366
Amortization of deferred financing costs 44,806 94,912
Write-off of capitalized offering costs 0 513,646
Amortization adjustment to debt discount 0 (29,984)
Change in fair value of warrant and conversion feature liability (1,633,333) 408,692
Impairment of goodwill and intangible assets 68,311 207,285
Changes in assets and liabilities:    
Accounts receivable (2,780,122) (27,195)
Other receivables 113,303 283,704
Due from affiliates 2,191 15,892
Prepaid expenses and other current assets (10,158) (92,182)
Deferred financing costs 0 (43,330)
Other assets (8,916) 3,181
Accounts payable and accrued liabilities 3,653,211 1,024,991
Deferred rent liability 53,514 57,907
Medical liabilities (902,478) 1,410,160
Net cash used in operating activities (8,139,078) (1,839,125)
Cash flows from investing activities:    
Change in restricted cash (235,058) 0
Proceeds from sale of ACC assets 0 15,000
Decrease in cash and cash equivalents resulting from deconsolidation of variable interest entities (858,670) 0
Property and equipment acquired (297,561) (262,108)
Net cash used in investing activities (1,391,289) (247,108)
Cash flows from financing activities:    
Proceeds from issuance of convertible note payable 4,990,000 0
Proceeds from issuance of note payable - related party 5,000,000 0
Repayments on convertible notes 0 (470,000)
Proceeds from notes payable 400,000 100,000
Principal payments on notes payable (400,000) (6,527,500)
Proceeds from line of credit 112,500 0
Repayments on lines of credit (150,000) (1,006,000)
Distributions to noncontrolling interest (1,200,000) (702,642)
Proceeds from exercise of warrants and vested restricted stock 172,068 0
Proceeds from issuance of common stock 0 200,000
Payment to noncontrolling interest for equity interest 0 (251,852)
Net cash provided by financing activities 8,924,568 6,342,001
Net change in cash and cash equivalents (605,799) 4,255,768
Cash and cash equivalents, beginning of year 9,270,010 5,014,242
Cash and cash equivalents, end of year 8,664,211 9,270,010
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION:    
Interest paid 23,532 521,341
Income taxes paid 30,902 176,587
NON-CASH FINANCING ACTIVITIES:    
Issuance of common stock on conversion of 8% warrants and notes 0 3,060,000
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest 0 553,851
Change in noncontrolling interest ownership 0 338,032
Tenant improvement allowance 0 659,360
Note receivable related to sale of ACC asset 0 51,000
Convertible debt reclassified to accounts payable 0 100,000
Common stock issued for acquisition of intangible assets 0 1,312,500
Reclassification of derivative liability to equity 1,177,778 0
Relative fair value of warrant included in debt discount 6,880 0
Reclassification of mezzanine equity to permanent equity 7,077,778 0
Reclassification of noncontrolling interest to due to acquisition of BAHA noncontrolling interest 183,408 0
Warrants issuable for debt guarantee 161,000 0
Series A Preferred Stock [Member]    
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss   0
Cash flows from financing activities:    
Proceeds from the issuance of preferred stock and warrants 0 10,000,000
NON-CASH FINANCING ACTIVITIES:    
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest   0
Series B Preferred Stock [Member]    
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss 0 0
Cash flows from financing activities:    
Proceeds from the issuance of preferred stock and warrants $ 0 4,999,995
NON-CASH FINANCING ACTIVITIES:    
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest   $ 0